News on bioinformatics, software, genome analysis, variant classification, and IT in genetics, genomics, and molecular diagnostics.
The companies will share bioinformatics and NGS expertise to speed the identification of diseases, accelerate drug discovery, and find "genomic shields."
The companies will market Agena's MassArray Dx system with HeartGenetics' HeartDecode genetic testing software and cardiovascular assays.
Bioinformatics firm Berg is combining multi-omics data from the Department of Defense's Center for Prostate Disease Research in search of biomarkers.
The new funding brings the total that the firm has raised in its history to €23 million, including €16 million in equity, and €7 million in debt instruments.
The assay combines high-throughput drug screening of live, patient-derived tumor cells with DNA sequencing and data analysis to match patients with drug therapies.
